Conclusions Across preclinical and translational studies, GLP-1RAs have emerged as promising candidates for NDD therapy, consistently modulating convergent mechanisms of pathology: IR, mitochondrial dysfunction, oxidative stress, proteostasis failure, synaptic loss, and neuroinflammation
Think of insulin as the key that unlocks the cells so glucose in your bloodstream can enter them
GLP-1, on the other hand, targets the physiological aspects of addiction, making it a complementary addition to behavioral therapies
The largest improvement was seen in satisfaction with sex life, which increased by 46.54% from baseline
In Physician's Desk Reference
Actual weight lost is dependent on a number of factors but many clients lose around 5% of their initial body weight